---
figid: PMC10525839__biomedicines-11-02346-g006
pmcid: PMC10525839
image_filename: biomedicines-11-02346-g006.jpg
figure_link: /pmc/articles/PMC10525839/figure/biomedicines-11-02346-f006/
number: Figure 6
figure_title: ''
caption: Pathway signaling scores calculated using nCounter 4.0 Advanced Analysis
  2.0 software. MYXV- and MYXVÎ”SERP2-inoculated cells were compared to the same mock-infected
  cell type at 4 hpi. JAK-STAT and Cytokine/Chemokine Signaling scores were increased
  in canine FBs following virus infection, but not in sarcoma cells (STS-1 and STS-2).
article_title: Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue
  Sarcoma.
citation: Laura V. Ashton, et al. Biomedicines. 2023 Sep;11(9):2346.
year: '2023'

doi: 10.3390/biomedicines11092346
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI

keywords:
- cytokines
- oclacitinib
- oncolytic virus
- dogs
- cancer

---
